DeepMed Research

HOLOGIC, INC.

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Prospective Case Collection Study of Contrast-Enhanced Mammography Imaging Acquired on a New Investigational Device

Not Applicable

Recruiting

Conditions: Breast Screening

Interventions: Device: CEM Exam in Investigational Device

First Posted Date: 2024-10-10

Last Posted Date: 2025-03-17

Lead Sponsor: Hologic, Inc.

Target Recruit Count: 75

Registration Number: NCT06636539

Locations: 🇺🇸
Solis Mammography Memorial Village, Houston, Texas, United States

Prospective Case Collection Study for New Mammography Technologies

Not Applicable

Recruiting

Conditions: Mammography

Interventions: Device: Mammography

First Posted Date: 2022-01-20

Last Posted Date: 2025-02-07

Lead Sponsor: Hologic, Inc.

Target Recruit Count: 7500

Registration Number: NCT05199701

Locations: 🇺🇸
Corewell Health, Grand Rapids, Michigan, United States
🇺🇸
Banner MD Anderson Cancer Center, Gilbert, Arizona, United States
🇺🇸
Southwest Medical Imaging, Gilbert, Arizona, United States

and more 11 locations

A Prospective, Multi-site Clinical Study to Collect User Feedback Using Affirm® Contrast Biopsy

Not Applicable

Completed

Conditions: Breast Cancer

Interventions: Device: Affirm Contrast Biopsy procedure

First Posted Date: 2020-12-17

Last Posted Date: 2023-10-16

Lead Sponsor: Hologic, Inc.

Target Recruit Count: 67

Registration Number: NCT04671329

Locations: 🇺🇸
Mayo Clinic, Phoenix, Arizona, United States
🇺🇸
University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States

RF Ablation of the Trigone for the Treatment of UUI

Not Applicable

Suspended

Conditions: Urgent Urinary Incontinence

Interventions: Device: selective bladder denervation using RF energy

First Posted Date: 2020-05-29

Last Posted Date: 2024-02-28

Lead Sponsor: Hologic, Inc.

Target Recruit Count: 225

Registration Number: NCT04408352

Locations: 🇺🇸
Regional Urology, LLC, Shreveport, Louisiana, United States
🇺🇸
UPMC Magee Womens Hospital, Pittsburgh, Pennsylvania, United States
🇺🇸
Alleghany Health Network, Pittsburgh, Pennsylvania, United States

and more 3 locations

Evaluating Image Quality and Comfort of an Investigational Curved Paddle Compared to a Standard Paddle

Completed

Conditions: Breast Cancer

Interventions: Device: New investigational curved paddle

First Posted Date: 2018-08-02

Last Posted Date: 2025-05-21

Lead Sponsor: Hologic, Inc.

Target Recruit Count: 443

Registration Number: NCT03611543

Locations: 🇺🇸
Stamford Hospital, Stamford, Connecticut, United States
🇺🇸
Elizabeth Wende Breast Clinic, Rochester, New York, United States
🇺🇸
Solis Mammagroaphy, Addison, Texas, United States

and more 1 locations

Rapid Amniotic Fluid (AF) Test and a Non-Invasive Vaginal Fluid (VF) Test

Not Applicable

Withdrawn

Conditions: Intra-Amniotic Infection of Foetus

Interventions: Diagnostic Test: Perilynx Analyzer to measure AF and VF fluid

First Posted Date: 2018-04-13

Last Posted Date: 2018-07-30

Lead Sponsor: Hologic, Inc.

Registration Number: NCT03497234

Locations: 🇺🇸
Good Samaritan Hospital, Long Beach, California, United States
🇺🇸
Regional Obstetrical Consultants, Chattanooga, Tennessee, United States
🇺🇸
Willis Knighton, Shreveport, Louisiana, United States

and more 2 locations

Brevera™ Breast Biopsy System Data Collection Study

Completed

Conditions: Breast Cancer Female

Interventions: Device: Brevera Breast Biopsy System

First Posted Date: 2018-03-07

Last Posted Date: 2024-10-08

Lead Sponsor: Hologic, Inc.

Target Recruit Count: 500

Registration Number: NCT03456583

Locations: 🇫🇷
Institut régional du Cancer de Montpellier, Montpellier, France
🇮🇹
Radiologia Senologica, Milan, Italy
🇳🇱
Noordwest Ziekenhuisgroep, Alkmaar, Netherlands

and more 3 locations

A Post-Market Clinical Trial to Evaluate the Performance and Operation of the Brevera Breast Biopsy System

Completed

Conditions: Breast Cancer Female

Interventions: Device: Breast Biopsy

First Posted Date: 2017-10-03

Last Posted Date: 2024-12-04

Lead Sponsor: Hologic, Inc.

Target Recruit Count: 525

Registration Number: NCT03300206

Locations: 🇺🇸
Washington University, Saint Louis, Missouri, United States
🇺🇸
Kensington Medical Center - Kaiser Permanente, Kensington, Maryland, United States
🇺🇸
Magee-Womens Hospital of UPMC, Pittsburgh, Pennsylvania, United States

and more 4 locations

Clinical Evaluation of the Aptima® Combo 2® Assay Using the Panther® System in Female Urine Samples

Terminated

Conditions: Chlamydia Trachomatis
Gonorrhea

First Posted Date: 2016-06-10

Last Posted Date: 2017-03-24

Lead Sponsor: Hologic, Inc.

Target Recruit Count: 1766

Registration Number: NCT02795975

Locations: 🇺🇸
Geneuity, Maryville, Tennessee, United States
🇺🇸
Brownstone Clinical Trials, Irving, Texas, United States
🇺🇸
LabCorp, Burlington, North Carolina, United States

and more 15 locations

Evaluation of the HSV 1 & 2 Assay in Specimens From Symptomatic Subjects

Completed

Conditions: Herpes Simplex Infections

First Posted Date: 2014-10-21

Last Posted Date: 2017-08-14

Lead Sponsor: Hologic, Inc.

Target Recruit Count: 839

Registration Number: NCT02270099

Locations: 🇺🇸
Perimeter Institute for Clinical Research, Inc. (PICR Clinic), Atlanta, Georgia, United States
🇺🇸
Indiana University School of Medicine, Indianapolis, Indiana, United States
🇺🇸
Planned Parenthood Gulf Coast, Inc., Houston, Texas, United States

and more 19 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy